- RESEARCH HIGHLIGHT
- 15 May 2026
The personalized treatment encourages the immune system to attack the tumours called glioblastomas.
Trending
- miR-195-5p controls apoptotic cascade by regulating the XIAP/BCL2/Survivin network in colorectal cancer
- Wrexham man’s headache turns out to be terminal brain cancer
- Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
- Steel Particulate Matter Prompts Cyclophosphamide for Injection Recall
- Amy Dowden says Strictly Come Dancing partner Carlos Gu convinced her not to quit dancing
- Navigating Insurance Hurdles for Oral AML Therapy Access
- Ris-Rez Hits PFS End Point in Phase 3 Osteosarcoma Trial
- Cretostimogene Grenadenorepvec Shows Complete Responses in NMIBC
Wednesday, July 29
